![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precis... Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration. Show more
WATERTOWN, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), today announced that it is advancing its goal to preserve capital by...
ENLIGHTEN 1 trial did not meet its primary endpoint Company plans to evaluate full dataset and path forward WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq:...
WATERTOWN, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting...
WATERTOWN, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the “Company” or “Lyra”), a clinical-stage biotech developing long-acting, anti-inflammatory...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0002 | -0.0691562932227 | 0.2892 | 0.3149 | 0.2711 | 1078298 | 0.2993646 | CS |
4 | 0.0152 | 5.55149744339 | 0.2738 | 0.3149 | 0.2532 | 1897064 | 0.27815854 | CS |
12 | -4.411 | -93.8510638298 | 4.7 | 5.65 | 0.2532 | 4289032 | 0.48642173 | CS |
26 | -4.941 | -94.4741873805 | 5.23 | 6.79 | 0.2532 | 2139563 | 0.92291859 | CS |
52 | -3.021 | -91.2688821752 | 3.31 | 6.79 | 0.2532 | 1217768 | 1.30744353 | CS |
156 | -7.191 | -96.1363636364 | 7.48 | 9.98 | 0.2532 | 460421 | 1.74642719 | CS |
260 | -20.711 | -98.6238095238 | 21 | 22 | 0.2532 | 358937 | 2.70404424 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions